Continuous capnography measures the partial pressure of CO2 in exhaled breath (end-tidal CO2 or ETCO2, normal 35 to 45 mmHg) and the respiratory rate. Compared with pulse oximetry, capnography provides the earliest objective signal of opioid-induced hypoventilation: rising ETCO2 reflects accumulating CO2 from inadequate ventilation, and a flattening or absent waveform reflects apnea. Pulse oximetry lags significantly, especially when supplemental oxygen is in place, because oxygen saturation can remain in the 90s even when minute ventilation has fallen and CO2 has climbed; SpO2 drop is therefore a late sign. Recommended monitoring for high-risk PCA patients (sleep apnea, obesity, comorbid sedatives, opioid-naive, elderly, OSA risk score, prior respiratory event): (1) continuous capnography with ETCO2 and waveform, (2) continuous pulse oximetry, (3) frequent sedation scale (POSS) and RR observations, (4) two-nurse double check at every PCA program change. The nurse intervenes when ETCO2 rises above 50 to 55 mmHg or 10 mmHg above baseline, RR drops below 10, sedation rises to POSS 3 or 4, or waveform becomes erratic — without waiting for SpO2 to fall. Believing capnography is unnecessary above 92 percent SpO2 reflects the exact knowledge gap that has caused PCA deaths.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.